Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunocore Holdings plc

30.23
-0.2050-0.67%
Mar 21 13:21 EST
Volume:161.43K
Turnover:4.93M
Market Cap:1.51B
PE:-29.58
High:30.97
Open:30.02
Low:29.22
Close:30.43
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h
More
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h

BMY Gets EC Nod for Opdivo Plus Yervoy in First-Line Colorectal Cancer

Zacks
·
24 Dec 2024

Immunocore Doses First Patient in Phase 1 Trial of Potential Cancer Treatment

MT Newswires Live
·
23 Dec 2024

Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term

Zacks
·
23 Dec 2024

Immunocore Announces First Patient Dosed in the Phase 1 Trial of Imc-P115c, a Half-Life Extended (Hle) Immtac Candidate in Patients With Tumors That Express Prame

THOMSON REUTERS
·
23 Dec 2024

Immunocore announces treatment of first patient in Phase 1/2 trial of IMC-R117C

TIPRANKS
·
17 Dec 2024

Immunocore Announces Treatment of First Patient in the Phase 1/2 Trial of Imc-R117c Targeting Piwil1 in Advanced Gastrointestinal Cancers

THOMSON REUTERS
·
17 Dec 2024

Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?

Benzinga
·
13 Dec 2024

Immunocore Holdings Cut to Equal-Weight From Overweight by Morgan Stanley

Dow Jones
·
13 Dec 2024

Morgan Stanley Downgrades Immunocore Holdings to Equalweight From Overweight, Cuts Price Target to $35 From $74

MT Newswires Live
·
13 Dec 2024

All You Need to Know About Immunocore (IMCR) Rating Upgrade to Strong Buy

Zacks
·
12 Dec 2024

CORT's Dazucorilant Fails to Meet Goal in Neurologic Disorder Study

Zacks
·
12 Dec 2024

AnaptysBio Stock Down as Eczema Study Fails to Meet Goals

Zacks
·
12 Dec 2024

Immunocore Enrolls First Patient in Phase 3 Uveal Melanoma Trial

MT Newswires Live
·
11 Dec 2024

Immunocore, EORTC announce enrollment of first patient in Phase 3 ATOM trial

TIPRANKS
·
11 Dec 2024

Eortc and Immunocore Announce Enrolment of First Patient Onto the Only Active Phase 3 Adjuvant Trial in Uveal Melanoma

THOMSON REUTERS
·
11 Dec 2024

Incyte's Late-stage NSCLC Study Meets Primary and Secondary Goals

Zacks
·
09 Dec 2024

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."